Ixchiq Wins FDA Approval as World’s First Chikungunya Vaccine
XTalks
NOVEMBER 15, 2023
The FDA says chikungunya is an emerging global health threat as at least 5 million cases of chikungunya virus infection have been reported in the last 15 years. Today’s approval addresses an unmet medical need and is an important advancement in the prevention of a potentially debilitating disease with limited treatment options.”
Let's personalize your content